NLM Digital Collections

Search

Start Over Subjects Drug-Related Side Effects and Adverse Reactions ✖Remove constraint Subjects: Drug-Related Side Effects and Adverse Reactions

5. Patients taking their own medications while in the hospital

Publication:
[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2012
Subject(s):
Inpatients
Medication Errors -- prevention & control
Medication Systems, Hospital -- organization & administration
Ownership
Pharmaceutical Preparations -- administration & dosage
Self Administration
Documentation
Drug-Related Side Effects and Adverse Reactions
Patient Education as Topic
Risk Assessment
Humans
Pennsylvania
United States

7. E14 clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs--questions and answers (R3)

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, June 2017
Subject(s):
Arrhythmias, Cardiac -- chemically induced
Arrhythmias, Cardiac -- diagnosis
Cardiac Electrophysiology -- methods
Cardiac Electrophysiology -- standards
Drug Approval
Electrocardiography -- standards
Long QT Syndrome -- chemically induced
Cardiotoxins
Clinical Trials as Topic
Congresses as Topic
Diagnosis, Computer-Assisted
Drug-Related Side Effects and Adverse Reactions
International Cooperation
Pharmaceutical Preparations -- administration & dosage
Reference Standards
Research Design
Sex Factors
Humans
Europe
Japan
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

9. Poisoning by bin-iodide of mercury: report of a case of poisoning by bin-iodide of mercury, occurring at Fort Gratiot, Michigan, June 27, 1869, to the St. Clair and Sanilac County Medical Society

Author(s):
Taylor, M. K. (Morse K.), 1823-1889, author
Publication:
Port Huron, Mich. : Port Huron Times Company, 1870
Subject(s):
Mercury Compounds -- poisoning
Iodides -- poisoning
Drug-Related Side Effects and Adverse Reactions
Michigan

19. Hazardous spills: the safe handling of hazardous drugs

Publication:
[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2008
Subject(s):
Chemical Hazard Release -- prevention & control
Drug-Related Side Effects and Adverse Reactions
Environmental Exposure -- prevention & control
Hazardous Substances
Occupational Exposure -- prevention & control
Refuse Disposal -- methods
Safety Management -- methods
Guideline Adherence
Guidelines as Topic
Health Personnel
Inpatients
Program Development
Humans
Pennsylvania
United States

20. On the injurious effects of mineral poisons in the practice of medicine: comprising an epitome and commentary on the system of Luigi Cornaro for attaining old age, and on the new system of medicine of F.V. Raspail (Every man his own physician), to which the Montyon Prize of 10,000 f. was lately adjudged at Paris, embracing all the details necessary for person to give this system a trial &c. &c

Author(s):
Prater, Horatio.
Publication:
London : Sherwood and Co., 1846
Subject(s):
Drug-Related Side Effects and Adverse Reactions
Inorganic Chemicals -- adverse effects
Health Behavior
Longevity
Phytotherapy
Cornaro, Luigi, 1475-1566.
Raspail, F.-V. (François-Vincent), 1794-1878.

22. Falls rates improved in Southeastern Pennsylvania: the impact of a regional initiative to standardize falls reporting

Publication:
[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2012
Subject(s):
Accidental Falls -- prevention & control
Accidental Falls -- statistics & numerical data
Documentation -- standards
Interinstitutional Relations
Mandatory Reporting
Patient safety
Regional Medical Programs -- organization & administration
Aged
Data Collection -- methods
Drug-Related Side Effects and Adverse Reactions
Health Care Surveys
Hospitals
Risk Assessment
Humans
Pennsylvania
United States

24. Postmarketing adverse event reporting for medical products and dietary supplements during a pandemic

Publication:
Silver Spring, MD : Office of Counterterrorism and Emerging Threats, May 2020
Subject(s):
Dietary Supplements -- adverse effects
Drug-Related Side Effects and Adverse Reactions
Equipment Design -- adverse effects
Equipment Safety
Product Surveillance, Postmarketing
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

27. Severely debilitating or life-threatening hematologic disorders: nonclinical development of pharmaceuticals

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, March 2019
Subject(s):
Drug Evaluation, Preclinical -- standards
Hematologic Diseases -- drug therapy
Animals
Carcinogenicity Tests
Cytotoxicity Tests, Immunologic
Drug Therapy, Combination
Drug-Related Side Effects and Adverse Reactions
Immunologic Tests
Mutagenicity Tests
Pediatrics
Pharmacokinetics
Photochemistry
Safety
Toxicity Tests
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

28. REMS: FDA's application of statutory factors in determining when a REMS is necessary

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, April 2019
Subject(s):
Drug Evaluation -- legislation & jurisprudence
Risk Evaluation and Mitigation -- legislation & jurisprudence
Cost of Illness
Drug-Related Side Effects and Adverse Reactions
Health Services Accessibility
Prescription Drugs -- adverse effects
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.
United States.

29. Oncology pharmaceuticals: reproductive toxicity testing and labeling recommendations

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, May 2019
Subject(s):
Antineoplastic Agents -- adverse effects
Mutagenicity Tests -- standards
Neoplasms -- drug therapy
Reproduction -- drug effects
Teratogens
Toxicity Tests -- standards
Contraception
Drug-Related Side Effects and Adverse Reactions
Fertility
Geriatrics
Pediatrics
Postmenopause
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

30. Testing of glycerin, propylene glycol, maltitol solution, hydrogenated starch hydrolysate, sorbitol solution, and other high-risk drug components for diethylene glycol and ethylene glycol: guidance for industry

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, May 2023
Subject(s):
Drug Contamination
Drug Industry
Drug-Related Side Effects and Adverse Reactions
Ethylene Glycols
Glycerol
Government Regulation
Propylene Glycol
Sorbitol
United States